In a study to better understand how to treat inflammatory bowel disease at the Weizmann Institute of Science. Led by the group of Prof. Eran Elinav of the Systems Immunology Department, in collaboration with the Molecular Genetics Department’s Prof. Rotem Sorek and a Weizmann spinoff company - BiomX Inc., published their findings in the prestigious journal Cell.

ד"ר רותי בן שלומי וד"ר חן טרדונסקי עבדו באותו המסדרון במכון ויצמן והתעניינו באותה בעיה עד שהחליטו לשלב כוחות ולבנות מחשב על: "לייטסולבר" הוא מחשב אופטי מבוסס קרני לייזר והוא יכול לתרום לפתרון בעיות מסובכות בלוגיסטיקה, רפואה, בטחון ועוד. בן שלומי: "אנחנו לא המחשב האופטי הראשון בעולם אבל בכל המתחרים יש אלקטרוניקה, והיא הופכת לצוואר הבקבוק"

LightSolver is a spinoff of Yeda from the Weizmann Institute of Science

Yeda spinoff, Xinteza API, has recently revealed a new source of cannabinoid biosynthesis that does not involve cannabinoids or cannabis. This breakthrough was discovered in research led by Professor Asaph Aharoni, Scientific Co-Founder of Xinteza and Head of the Weizmann Institute of Science Plant Metabolics Lab as well as Head of Weizmann’s Plant and Environmental Sciences Department.

“This discovery is a major milestone in the path to uncover and exploit rare and new cannabinoid molecules with potentially novel pharmacological activities”, says Aharoni.

A seed investment has been made in ClimateCrop - photosynthesis enhancement Ltd, a spinoff from Yeda, using state-of-the-art gene editing techniques to improve plant growth efficiency.

The Weizmann Institute managed to create a mouse embryo without fertilization and outside the uterus by challenging one of the most basic conditions of life. Hopefully, this breakthrough will open up a world of possibilities, from fertility problems to organs available for transplantation in the near future. Prof. Yaakov Hanna of the Weizmann Institute is our guest

These are the spinouts that caught our eye over the past month. Here's why they should be on your radar, too.

We are thrilled to announce the launch of Renewal Bio, a Yeda spinoff company leveraging breakthrough stem cell technologies from Prof. Jacob Hanna's lab, to drive therapeutic advancements in genetic diseases, infertility, longevity and other disease areas.

Photomyne Ltd. is a Yeda - Technology Transfer Company of Weizmann Institute of Science portfolio company that leverages AI technology to empower families worldwide to scan, save and share their most precious photos and memories.

The Nancy and Stephen Grand Israel National Center for Personalized Medicine at the Weizmann Institute is an advanced research facility that strives to promote the field of personalized medicine by providing Israeli academic, medical and biomedical industry researchers with access to state-of-the-art Genomics, Bioinformatics, Proteomics, High Throughput Screening and Medicinal Chemistry.